BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19306133)

  • 1. Correlation between Aurora-A expression and the prognosis of cervical carcinoma patients.
    Zhang W; Wang J; Liu SJ; Hua W; Xin XY
    Acta Obstet Gynecol Scand; 2009; 88(5):521-7. PubMed ID: 19306133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma.
    Reiter R; Gais P; Jütting U; Steuer-Vogt MK; Pickhard A; Bink K; Rauser S; Lassmann S; Höfler H; Werner M; Walch A
    Clin Cancer Res; 2006 Sep; 12(17):5136-41. PubMed ID: 16951231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis.
    Royce ME; Xia W; Sahin AA; Katayama H; Johnston DA; Hortobagyi G; Sen S; Hung MC
    Cancer; 2004 Jan; 100(1):12-9. PubMed ID: 14692019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
    Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
    Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.
    Tanaka E; Hashimoto Y; Ito T; Okumura T; Kan T; Watanabe G; Imamura M; Inazawa J; Shimada Y
    Clin Cancer Res; 2005 Mar; 11(5):1827-34. PubMed ID: 15756006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Aurora-A expression in renal cell carcinoma.
    Kurahashi T; Miyake H; Hara I; Fujisawa M
    Urol Oncol; 2007; 25(2):128-33. PubMed ID: 17349527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
    Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
    Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.
    Qin W; Dong P; Ma C; Mitchelson K; Deng T; Zhang L; Sun Y; Feng X; Ding Y; Lu X; He J; Wen H; Cheng J
    Oncogene; 2012 Sep; 31(36):4067-75. PubMed ID: 22179829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
    Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
    Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance.
    Wang R; Wang JH; Chu XY; Geng HC; Chen LB
    Clin Biochem; 2009 May; 42(7-8):641-7. PubMed ID: 19232520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone.
    Doll CM; Prystajecky M; Eliasziw M; Klimowicz AC; Petrillo SK; Craighead PS; Hao D; Diaz R; Lees-Miller SP; Magliocco AM
    Radiother Oncol; 2010 Nov; 97(2):352-9. PubMed ID: 20934765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated aromatase expression correlates with cervical carcinoma progression.
    Veerapaneni P; Kirma N; Nair HB; Hammes LS; Hall KL; Tekmal RR
    Gynecol Oncol; 2009 Sep; 114(3):496-500. PubMed ID: 19555998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer.
    Gerlach U; Kayser G; Walch A; Hopt U; Schulte-Mönting J; Werner M; Lassmann S
    J Pathol; 2006 Mar; 208(4):462-72. PubMed ID: 16402339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of granzyme B expression in invasive cervical carcinoma correlates to poor response to treatment.
    Guzman VB; Silva ID; Brenna SM; Carvalho CR; Ribalta JC; Gerbase-Delima M
    Cancer Invest; 2008 Jun; 26(5):499-503. PubMed ID: 18568772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.
    Yamashita S; Chujo M; Tokuishi K; Anami K; Miyawaki M; Yamamoto S; Kawahara K
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1303-8. PubMed ID: 19818968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.
    Otto W; Fritsche HM; Wild PJ; Wieland WF; Hartmann A; Burger M; Hofstädter F; Denzinger S
    Pathol Res Pract; 2011 Mar; 207(3):161-3. PubMed ID: 21247708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2.
    Zijlmans HJ; Fleuren GJ; Baelde HJ; Eilers PH; Kenter GG; Gorter A
    J Pathol; 2006 Mar; 208(4):507-17. PubMed ID: 16435282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.